Aibotics, Inc. (AIBT) stock
AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Aibotics total assets
Total assets on the balance sheet at the end of each period.
Aibotics's total assets was $549.59K at Jun 30, 2026. For fiscal 2025 it was $874.67K, down 40.0% from the year before. The highest annual figure on record is $2.22M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $874.67K | -40.0% |
| FY2024 | Dec 31, 2024 | $1.46M | -34.4% |
| FY2023 | Dec 31, 2023 | $2.22M | +472.9% |
| FY2022 | Dec 31, 2022 | $387.40K | -69.5% |
| FY2021 | Dec 31, 2021 | $1.27M | +1046.8% |
| FY2020 | Dec 31, 2020 | $110.75K | -90.9% |
| FY2019 | Dec 31, 2019 | $1.22M | -19.0% |
| FY2018 | Dec 31, 2018 | $1.50M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $549.59K | -53.6% |
| Q1 FY2026 | Mar 31, 2026 | $771.23K | -39.0% |
| Q4 FY2025 | Dec 31, 2025 | $874.67K | -40.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.02M | -38.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.19M | -37.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.26M | -41.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.46M | -34.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.64M | +417.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.89M | +455.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.14M | +498.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.22M | +472.9% |
| Q3 FY2023 | Sep 30, 2023 | $317.73K | -27.8% |
| Q2 FY2023 | Jun 30, 2023 | $339.90K | -56.7% |
| Q1 FY2023 | Mar 31, 2023 | $358.28K | -75.9% |
| Q4 FY2022 | Dec 31, 2022 | $387.40K | -69.5% |
| Q3 FY2022 | Sep 30, 2022 | $440.17K | -53.7% |
| Q2 FY2022 | Jun 30, 2022 | $785.38K | +52.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.48M | +1340.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.27M | +1046.8% |
| Q3 FY2021 | Sep 30, 2021 | $950.14K | +96.0% |
| Q2 FY2021 | Jun 30, 2021 | $513.93K | -6.3% |
| Q1 FY2021 | Mar 31, 2021 | $103.05K | -83.1% |
| Q4 FY2020 | Dec 31, 2020 | $110.75K | -90.9% |
| Q3 FY2020 | Sep 30, 2020 | $484.78K | -67.9% |
| Q2 FY2020 | Jun 30, 2020 | $548.48K | -74.6% |
| Q1 FY2020 | Mar 31, 2020 | $609.81K | -59.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.22M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.51M | – |
| Q2 FY2019 | Jun 30, 2019 | $2.16M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.50M | – |
See a number that looks wrong?